Article Information
History
- December 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marta Galanti, PhD1,
- Sen Pei, PhD1,
- Teresa K. Yamana, PhD1,
- Frederick J. Angulo, PhD, DVM2,
- Apostolos Charos, Pharma.D., MSc3,
- David L. Swerdlow, MD2 and
- Jeffrey Shaman, PhD1,*
- 1Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032
- 2Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, 500 Arcola Road, Collegeville PA 19426
- 3Patient Health Impact, Pfizer Vaccines, Walton Oaks, Tadworth, UK, KT20 7NS
- ↵*Corresponding Author: Jeffrey Shaman, 722 W. 168th St., Mailman School of Public Health, Columbia University, New York, NY 10032 212-305-3590, jls106{at}cumc.columbia.edu
Posted December 26, 2020.
The importance of continued non-pharmaceutical interventions during the upcoming SARS-COV-2 vaccination campaign
